Wenyu Shi Selected Research

Wenyu Shi Research Topics

Disease

14	Neoplasms (Cancer) 12/2023 - 06/2015
10	Lymphoma (Lymphomas) 04/2024 - 02/2015
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 01/2018
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2024 - 01/2019
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 02/2015
3	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2021
2	Brain Injuries (Brain Injury) 01/2024 - 12/2023
2	Disease Progression 01/2023 - 12/2021
2	Inflammation (Inflammations) 12/2022 - 11/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
1	COVID-19 04/2024
1	Pain (Aches) 03/2024
1	Neuralgia (Stump Neuralgia) 03/2024
1	Thrombocytopenia (Thrombopenia) 01/2024
1	Agranulocytosis (Granulocytopenia) 01/2024
1	Brain Diseases (Brain Disorder) 01/2024
1	Residual Neoplasm 12/2023
1	Bites and Stings (Sting) 12/2023
1	Leukemia 03/2023
1	Male Breast Neoplasms (Male Breast Cancer) 01/2023
1	Carcinogenesis 01/2023
1	Heart Failure 01/2023
1	Extranodal NK-T-Cell Lymphoma 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Periodontitis 08/2021
1	Cognitive Dysfunction 01/2021
1	Carcinoma (Carcinomatosis) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Dysbiosis 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Hyperplasia 11/2018

Drug/Important Bio-Agent (IBA)

4	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2017
3	Proteasome InhibitorsIBA 01/2024 - 01/2019
3	Bortezomib (Velcade)FDA Link 01/2024 - 01/2019
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2024 - 01/2019
3	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2023
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 09/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2024 - 11/2020
2	EnzymesIBA 12/2023 - 12/2022
2	oxybenzone (Solbar)FDA Link 03/2023 - 06/2022
2	Triclosan (pHisoHex)FDA Link 03/2023 - 06/2022
2	PhenolsIBA 03/2023 - 06/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2021
2	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2018
2	ibrutinibIBA 01/2020 - 01/2020
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 06/2015
1	Rituximab (Mabthera)FDA Link 04/2024
1	obinutuzumabIBA 04/2024
1	PPAR gammaIBA 03/2024
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2024
1	superoxide dismutase 2IBA 03/2024
1	PowdersIBA 03/2024
1	PPAR alphaIBA 03/2024
1	CreatinineIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	Fibrinogen (Factor I)FDA Link 01/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2023
1	Indicators and Reagents (Reagents)IBA 12/2023
1	InterferonsIBA 12/2023
1	Phosphotransferases (Kinase)IBA 12/2023
1	Guanosine Triphosphate (GTP)IBA 12/2023
1	sugemalimabIBA 11/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2023
1	Ubiquitin-Specific ProteasesIBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Deubiquitinating EnzymesIBA 01/2023
1	UbiquitinIBA 01/2023
1	ImmunosorbentsIBA 12/2022
1	LipopolysaccharidesIBA 12/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2022
1	NLR ProteinsIBA 12/2022
1	Sericins (Sericin)IBA 12/2022
1	Phenol (Carbolic Acid)FDA Link 06/2022
1	bisphenol AIBA 06/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Coloring Agents (Dyes)IBA 08/2021
1	Carbon DioxideIBA 08/2021
1	NeuropilinsIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	ASP3026IBA 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2019
1	bcr-abl Fusion ProteinsIBA 01/2019
1	Lysosomal-Associated Membrane Protein 1IBA 11/2018

Therapy/Procedure

8	Therapeutics 04/2024 - 01/2019
4	Radiotherapy 01/2024 - 01/2021
1	Aftercare (After-Treatment) 12/2023
1	Drug Therapy (Chemotherapy) 12/2023
1	Patient Readmission 01/2023
1	VAP-cyclo protocol 12/2021